Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Genomic Health Inc (NASDAQ:GHDX)

26.73
Delayed Data
As of Aug 27
 +0.78 / +3.01%
Today’s Change
23.00
Today|||52-Week Range
37.74
-16.39%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$842.9M

Company Description

Genomic Health, Inc. is a global healthcare company that provides actionable genomic information to personalize cancer treatment decisions. The company has a robust pipeline focused on developing tests to optimize the treatment of renal cell cancers, as well as additional treatment decisions in breast and colon cancers. It is dedicated to addressing the difficult challenges of cancer treatment by utilizing genomics to help physicians and patients choose the most appropriate treatment options with optimal confidence. Genomic Health was founded by Patrick F. Terry, Joffre B. Baker, Randal W. Scott and Steven Shak in August 2000 and is headquartered in Redwood City, CA.

Contact Information

Genomic Health, Inc.
301 Penobscot Drive
Redwood City California 94063
P:(650) 556-9300
Investor Relations:
(650) 569-2824

Employees

Shareholders

Other institutional67.59%
Individual stakeholders59.76%
Mutual fund holders26.60%

Top Executives

Kimberly J. PopovitsChairman, President & Chief Executive Officer
G. Bradley ColeChief Operating & Financial Officer
Steven ShakChief Scientific Officer
Paul AldridgeChief Information Officer & Senior Vice President
Phillip G. FebboChief Medical Officer